InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the full record of transactions filed by Kuhn Thomas, Chief Executive Officer. Officer active across 1 company, notably POXEL. Cumulatively, 5 disclosures have been published. Breakdown: 2 buys · 0 sell. Activity tracked since 24 August 2022. The latest transaction was disclosed on 29 January 2024 (Acquisition). Regulator: AMF. All data is accessible without signup.
Companies and markets linked to Kuhn Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
80,000 shares0ActionEuronext ParisISIN FR00124325162024DD948921
Canonical exit: 28 Apr 2024 (T+90)
150,000 shares0ActionEuronext ParisISIN FR00124325162023DD894028
80,000 shares0ActionEuronext ParisISIN FR00124325162023DD882619
Canonical exit: 27 Apr 2023 (T+90)
400,000 shares0ActionHors plateforme de négociationISIN FR00124325162022DD877946
150,000 shares0ActionHors plateforme de négociationISIN FR00124325162022DD858234
5 of 5 declarations
About Kuhn Thomas
Kuhn Thomas is the Chief Executive Officer of Poxel. He leads the company, which specializes in developing treatments for metabolic diseases. His role is crucial for the strategy and growth of Poxel in the pharmaceutical market.
